0 results available. Select is focused ,type to refine list, press Down to open the menu,
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a...
The following section summarizes insights on Genomma Lab Internacional SAB De CV's Revenue CAGR (5y):
We've identified the following companies as similar to Genomma Lab Internacional SAB De CV because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Revenue CAGR (5y) in the growth category include:
Five-year compound annual growth rate in revenue.
Revenue CAGR (5y) measures the five-year compound annual growth rate in Revenue.
Compound annual growth rate (CAGR) is a commonly used business and investing term that measures the growth of a metric over multiple periods. CAGRs are useful since they reduce the effect of volatility in specific periods, unlike arithmetic means.
You can find the calculation details for Genomma Lab Internacional’s Revenue CAGR outlined below. The calculation starts by listing values for Revenue for the last six fiscal years that are required to calculate CAGR:
| Fiscal Year | Revenue | YoY Growth |
|---|---|---|
| 2019-12-31T00:00:00.000Z | 12.713 B | |
| 2020-12-31T00:00:00.000Z | 13.87 B | 9.1% |
| 2021-12-31T00:00:00.000Z | 15.487 B | 11.7% |
| 2022-12-31T00:00:00.000Z | 16.82 B | 8.6% |
| 2023-12-31T00:00:00.000Z | 16.467 B | −2.1% |
| 2024-12-31T00:00:00.000Z | 18.607 B | 13.0% |
Using the values for Revenue listed in the table above, we can calculate three-year Revenue CAGR as follows:
Number of years = 5
Multiplier = Mex$ 18.607 B / Mex$ 12.713 B = 1.46
5 Year CAGR = 1.46 ^ (1/5) - 1 = 7.9%
Growth calculations are always made in the company’s reporting currency to ensure currency fluctuations do not impact the calculation. Genomma Lab Internacional’s reports in the MXN currency. You can read more about Revenue here and compound annual growth rate on Wikipedia. You may also find variants three-year Revenue CAGR, and seven-year Revenue CAGR useful.
The chart above depicts the distribution of revenue cagr (5y) for companies operating in the Healthcare sector in the Developing economic region. Over 1,010 companies were considered in this analysis, and 976 had meaningful values. The average revenue cagr (5y) of companies in the sector is 12.2% with a standard deviation of 16.3%.
Genomma Lab Internacional SAB De CV's Revenue CAGR (5y) of 7.9% ranks in the 44.0% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developing |
| Total Constituents | 1,016 |
| Included Constituents | 976 |
| Min | -24.0% |
| Max | 97.4% |
| Median | 9.6% |
| Mean | 12.2% |
| Standard Deviation | 16.3% |
You can find companies with similar revenue cagr (5y) using this stock screener.